retatrutide phase 2 nejm weight loss 48 weeks isn't a GLP-1. It's not a dual agonist. It's a triple hormone receptor agonist — activating GIP, GLP-1, and glucagon simultaneously. Three receptors. Three mechanisms. One protocol. Swipe to see what retatrutide phase 2 nejm 2023

Biochemistry, 55 (8), 12461253

#DigestiveHealth #Gastroenterology #HealthcareInnovation #IntegratedCare #MedicalEthics #MetabolicEndoscopy #ObesityManagement #PatientCenteredCare #Publications #RegulatoryAgencies #MarketAccess #MarketAccessToday Gastroenterologists Take Charge in Managing Obesity with Innovative Approaches To view or add a comment, sign in Why TESTOSTERONE matters in orthobiologics

[DOI] [PubMed] [Google Scholar] [156].Cao M, Mu X, Jiang C, Yang G, Chen H, Xue W, Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis

doi: 10.3390/ijms25052475